Gynecomastia: Review

Pediatric Endocrinology Reviews

Volumn 5, Issue 1, 2007, Pages 489-499

  Abaci, Ayhan ^a   Buyukgebiz, Atilla ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ACIBADEM HOSPITAL   (Turkey)

Author keywords

Androgens; Estrogens; Gynecomastia; Treatment

Indexed keywords

ANASTROZOLE; ANDROSTANOLONE; AROMATASE; CLOMIFENE CITRATE; DANAZOL; ESTRADIOL; GONADOTROPIN; PROLACTIN; RALOXIFENE; TAMOXIFEN; TESTOLACTONE; TESTOSTERONE; ESTROGEN;

BREAST CANCER; BREAST SURGERY; CHRONIC KIDNEY FAILURE; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; GYNECOMASTIA; HUMAN; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOGONADISM; LABORATORY TEST; MAMMOGRAPHY; MASTECTOMY; PHYSICAL EXAMINATION; PREPUBERTY; REVIEW; SOCIAL PSYCHOLOGY; TESTOSTERONE BLOOD LEVEL; THYROID FUNCTION; BLOOD; MALE;

ESTRADIOL; ESTROGENS; GYNECOMASTIA; HUMANS; MALE; PROLACTIN;

EID: 35148870919     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Lazala C, Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol Metab 2002;15:553-560
2. Ismail AA, Barth JH. Endocrinology of gynaecomastia. Ann Clin Biochem 2001;38:596-607
3. Braunstein GD. Gynecomastia. N Engl J Med 1993;328:490-495
4. Mathur R, Braunstein GD. Gynecomastia: pathomechanisms and treatment strategies. Horm Res 1997;48:95-102
5. Bembo SA, Carlson HE. Gynecomastia: its features and when and how to treat it. Cleve Clin J Med 2004;71:511-517
6. Reiter EO, Braunstein GD. Gynocomastia. In: Pescovitz OH, Eugster EA, 1th ed. Pediatric Endocrinology: Mechanism, Manifestations and Management. Philadelphia USA: A Wolters Kluwer Company Lipincott Williams and Wilkins 2004;350-359
7. Braunstein GD. Diagnosis and treatment of gynecomastia. Hosp Pract (Off Ed) 1993;28:37-46
8. Mahoney CP. Adolescent gynecomastia. Differential diagnosis and management. Pediatr Clin North Am 1990;37:1389-1404
9. Pearlman G, Carlson HE. Gynecomastia An Update. The Endocrinologist 2006;16:109-115
10. Barrett-Connor E, Khaw KT. Cigarette smoking and increased endogenous estrogen levels in men. Am J Epidemiol 1987;126:187-192
11. Galloway PJ, Donaldson MD, Wallace AM. Sex hormone binding globulin concentration as a prepubertal marker for hyperinsulinaemia in obesity. Arch Dis Child 2001;85:489-491
12. Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L, Taylor PR. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 1996;64(6):850-855
13. Bulard J, Mowszowicz I, Schaison G. Increased aromatase activity in pubic skin fibroblasts from patients with isolated gynecomastia. J Clin Endocrinol Metab 1987;64:618-623
14. Toda K, Terashima M, Kawamoto T, Sumimoto H, Yokoyama Y, Kuribayashi I, Mitsuuchi Y, Maeda T, Yamamoto Y, Sagara Y. Structural and functional characterization of human aromatase P-450 gene. Eur J Biochem 1990;193:559-565
15. Chen SA, Besman MJ, Sparkes RS, Zollman S, Klisak I, Mohandas T, Hall PF, Shively JE. Human aromatase: cDNA cloning, Southern blot analysis and assignment of the gene to chromosome 15. DNA 1988;7:27-38
16. Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B, Sebastian S. Organization of the human aromatase p450 (CYP19) gene. Semin Reprod Med 2004;22:5-9
17. Braunstein GD. Aromatase and gynecomastia. Endocr Relat Cancer 1999;6:315-324
18. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994;15:342-355
19. Toda K, Simpson ER, Mendelson CR, Shizuta Y, Kilgore MW. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Mol Endocrinol 1994;8(2):210-217
20. Ersoz H, Onde ME, Terekeci H, Kurtoglu S, Tor H. Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. Int J Androl 2002;25:312-316
21. Rohrich RJ, Ha RY, Kenkel JM, Adams WP. Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 2003; 111:909-923
22. Madlon-Kay DJ. 'Witch's milk'. Galactorrhea in the newborn. Am J Dis Child 1986;140:252-253
23. McKiernan J, Coyne J, Cahalane S. Histology of breast development in early life. Arch Dis Child 1988;63:136-139
24. McKiernan JF, Hull D. Prolactin, maternal estrogens and breast development in the newborn. Arch Dis Child 1981;56:770-774
25. Francis GL, Hoffman WH, Gala RR, McPherson JC, III, Zadinsky J. A relationship between neonatal breast size and cord blood testosterone level. Ann Clin Lab Sci 1990;20:239-244
26. th ed. Basic & Clinical Endocrinology. Lebenon: Appleton & Lange 1994;391-418
27. Nydick M, Bustos J, Dale JH, Rawson RW. Gynecomastia in adolescent boys. JAMA 1961;178:449-454
28. Fara GM, Del CG, Bernuzzi S, Bigatello A, Di PC, Scaglioni S, Chiumello G. Epidemic of breast enlargement in an Italian school. Lancet 1979;2:295-297
29. Lee PA. The relationship of concentrations of serum hormones to pubertal gynecomastia. J Pediatr 1975;86:212-215
30. Neyzi O, Alp H, Yalcindag A, Yakacikli S, Orphon A. Sexual maturation in Turkish boys. Ann Hum Biol 1975;2:251-259
31. Moore DC, Schlaepfer LV, Paunier L, Sizonenko PC. Hormonal changes during puberty: V. Transient pubertal gynecomastia: abnormal androgen-estrogen ratios. J Clin Endocrinol Metab 1984;58:492-499
32. Killeen J, Vanderburg D, Harlan WR. Application of weight-height ratios and body indices to juvenile populations-the National Health Examination Survey Data. J Chronic Dis 1978;31:529-357
33. Neuman JF. Evaluation and treatment of gynecomastia. Am Fam Physician 1997;55:1835-1850
34. LaFranchi SH, Parlow AF, Lippe BM, Coyotupa J, Kaplan SA. Pubertal gynecomastia and transient elevation of serum estradiol level. Am J Dis Child 1975;129:927-931
35. Albertsson-Wikland K, Rosberg S, Lannering B, Dunkel L, Selstam G, Norjavaara E. Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone and estradiol levels: a semilongitudinal study throughout puberty in healthy boys. J Clin Endocrinol Metab 1997;82:541-549
36. Large DM anderson DC. Twenty-four hour profiles of circulating androgens and estrogens in male puberty with and without gynaecomastia. Clin Endocrinol (Oxf) 1979;11:505-521
37. Dundar B, Dundar N, Erci T, Bober E, Buyukgebiz A. Leptin levels in boys with pubertal gynecomastia. J Pediatr Endocrinol Metab 2005;18:929-934
38. Biro FM, Lucky AW, Huster GA, Morrison JA. Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr 1990;116(3):450-455
39. Harlan WR, Grillo GP, Cornoni-Huntley J, Leaverton PE. Secondary sex characteristics of boys 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr 1979;95:293-297
40. Williams MJ. Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases. Am J Med 1963;34:103-112
41. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979;48:338-340
42. Ley S, Mozaffarian G, Leonard J, Highley M, Paulsen C. Palpable breast tissue versus gynecomastia as a normal physical findings. Clin Res 1980;24A
43. Carlson HE. Gynecomastia. N Engl J Med 1980;303:795-799
44. Andersen JA, Gram JB. Male breast at autopsy. Acta Pathol Microbiol Immunol Scand (A) 1982;90:191-197
45. Niewoehner CB, Nuttal FQ. Gynecomastia in a hospitalized male population. Am J Med 1984;77:633-638
46. Vermeulen A, Kaufman JM, Goemaere S, van PI. Estradiol in elderly men. Aging Male 2002;5:98-102
47. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-731
48. Castro-Magana M, Angulo M, Uy J. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med 1993;328:1297-1301
49. Cavanah SF, Dons RF. Partial 3 beta-hydroxysteroid dehydrogenase deficiency presenting as new-onset gynecomastia in a eugonadal adult male. Metabolism 1993;42:65-68
50. Einav-Bachar R, Phillip M, urbach-Klipper Y, Lazar L. Prepubertal gynaecomastia: aetiology, course and outcome. Clin Endocrinol (Oxf) 2004;61:55-60
51. Stratakis CA, Batista D, Sabnis G, Brodie A. Prepubertal gynaecomastia caused by medication or the aromatase excess syndrome. Clin Endocrinol (Oxf) 2004;61:779-780
52. Harigopal M, Murray MP, Rosen PP, Shin SJ. Prepubertal gynecomastia with lobular differentiation. Breast J 2005;11:48-51
53. Felner EI, White PC. Prepubertal gynecomastia: indirect exposure to estrogen cream. Pediatrics 2000;105:E55
54. Edidin DV, Levitsky LL. Prepubertal gynecomastia associated with estrogen-containing hair cream. Am J Dis Child 1982;136:587-588
55. Malozowski S, Stadel BV. Prepubertal gynecomastia during growth hormone therapy. J Pediatr 1995;126:659-661
56. Wilson JD, Aiman J, MacDonald PC. The pathogenesis of gynecomastia. Adv Intern Med 1980;25:1-32
57. Zadik Z, Pertzelan A, Kaufman H, Levin S, Laron Z. Gynaecomastia in two prepubertal boys with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Helv Paediatr Acta 1979;34(2):185-187
58. Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH. Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med 1977;87(4):398-403
59. Miyatake A, Noma K, Nakao K, Morimoto Y, Yamamura Y. Increased serum oestrone and oestradiol following spironolactone administration in hypertensive men. Clin Endocrinol (Oxf) 1978;9:523-533
60. Santen RJ, Kulin HE, Loriaux DL, Friend J. Spironolactone stimulation of gonadotropin secretion in boys with delayed adolescence. J Clin Endocrinol Metab 1976;43:1386-1390
61. Staiman VR, Lowe FC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 1997;50(6):929-933
62. Spence RW, Celestin LR. Gynaecomastia associated with cimetidine. Gut 1979;20(2):154-157
63. Castro-Magana M, Angulo M, Uy J. Elevated serum estradiol associated with increased androstenedione-testosterone ratio in adolescent males with varicocele and gynecomastia. Fertil Steril 1991;56(3):515-528
64. Aiman J, Brenner PF, MacDonald PC. Androgen and estrogen production in elderly men with gynecomastia and testicular atrophy after mumps orchitis. J Clin Endocrinol Metab 1980;50(2):380-386
65. Amory JK, Anawalt BD, Paulsen CA, Bremner WJ. Klinefelter's syndrome. Lancet 2000;356:333-335
66. Ford HC, Cooke RR, Keightley EA, Feek CM. Serum levels of free and bound testosterone in hyperthyroidism. Clin Endocrinol (Oxf) 1992;36:187-192
67. Tan YK, Birch CR, Valerio D. Bilateral gynaecomastia as the primary complaint in hyperthyroidism. J R Coll Surg Edinb 2001;46:176-177
68. Kumanov F. Prolactin secretion and gynecomastia. Vutr Boles 1983;22(6):103-110
69. Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G. Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 1998;79:202-211
70. Kleinberg DL, Davis JM, de CR, Van BB, Brecher M. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999;19:57-61
71. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004;64:2291-2314
72. Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med 1999;44:1085-1090
73. Handelsman DJ, Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 1993;22:145-161
74. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005;152:501-513
75. Baker HW, Burger HG, de Kretser DM, Dulmanis A, Hudson B, O'Connor S, Paulsen CA, Purcell N, Rennie GC, Seah CS, Taft HP, Wang C. A study of the endocrine manifestations of hepatic cirrhosis. Q J Med 1976;45:145-178
76. Handelsman DJ, Strasser S, McDonald JA, Conway AJ, McCaughan GW. Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clin Endocrinol (Oxf) 1995;43:331-337
77. Farthing MJ, Green JR, Edwards CR, Dawson AM. Progesterone, prolactin and gynaecomastia in men with liver disease. Gut 1982;23:276-279
78. Maruyama Y, Adachi Y, Aoki N, Suzuki Y, Shinohara H, Yamamoto T. Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: role of sex hormone-binding globulin. Gastroenterol Jpn 1991;26:435-439
79. Gavaler JS, Rosenblum ER, Deal SR, Bowie BT. The phytoestrogen congeners of alcoholic beverages: current status. Proc Soc Exp Biol Med 1995;208:98-102
80. Madersbacher S, Grunberger T, Maier U. Andrological status before and after liver transplantation. J Urol 1994;151(5):1251-1254
81. Foppiani L, Bernasconi D, Del MP, Marugo A, Toncini C, Marugo M. Leydig cell tumour-induced bilateral gynaecomastia in a young man: endocrine abnormalities. Andrologia 2005;37:36-39
82. Ghazi AA, Mofid D, Rahimi F, Marandi H, Nasri H, Afghah S. Oestrogen and cortisol producing adrenal tumour. Arch Dis Child 1994;71:358-359
83. Balakumar T, Perry LA, Savage MO. Adrenocortical adenoma-an unusual presentation with hypersecretion of oestradiol androgens and cortisol. J Pediatr Endocrinol Metab 1997;10:227-229
84. Itami RM, Amundson GM, Kaplan SA, Lippe BM. Prepubertal gynecomastia caused by an adrenal tumor. Diagnostic value of ultrasonography. Am J Dis Child 1982;136:584-586
85. Sherbet DP, Tiosano D, Kwist KM, Hochberg Z, Auchus RJ. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. J Biol Chem 2003;278:48563-48569
86. Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, Yue W, Mitsiades CS, Flor AW, Chrousos GP. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 1998;83:1348-1357
87. Ting AC, Chow LW, Leung YF. Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia. Am Surg 2000;66:38-40
88. Riepe FG, Baus I, Wiest S, Krone N, Sippell WG, Partsch CJ. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole. Horm Res 2004;62:113-118
89. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004;145:71-76
90. Plourde PV, Kulin HE, Santner SJ. Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies. Am J Dis Child 1983;137:1080-1082
91. Kuhn JM, Laudat MH, Roca R, Dugue MA, Luton JP, Bricaire H. Gynecomastia: effect of prolonged treatment with dihydrotestosterone by the percutaneous route. Presse Med 1983;12:21-25
92. Zachmann M, Eiholzer U, Muritano M, Werder EA, Manella B. Treatment of pubertal gynaecomastia with testolactone. Acta Endocrinol Suppl (Copenh) 1986;279:218-226
93. Madanes AE, Farber M. Danazol. Ann Intern Med 1982;96:625-630
94. Jones DJ, Holt SD, Surtees P, Davison DJ, Coptcoat MJ. A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. Ann R Coll Surg Engl 1990;72:296-298
95. Plourde PV, Reiter EO, Jou HC, Desrochers PE, Rubin SD, Bercu BB, Diamond FB, Jr, Backeljauw PF. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004;89:4428-4433
96. Harvey HA, Kimura M, Hajba A. Tamoxifen: an evaluation of its safety profile. Breast 2006;15:142-157
97. Khan HN, Rampaul R, Blarney RW. Management of physiological gynaecomastia with tamoxifen. Breast 2004;13:61-65
98. McDermott MT, Hofeldt FD, Kidd GS. Tamoxifen therapy for painful idiopathic gynecomastia. South Med J 1990;83:1283-1285
99. Parker LN, Gray DR, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism 1986;35:705-708
100. LeRoith D, Sobel R, Glick SM. The effect of clomiphene citrate on pubertal gynaecomastia. Acta Endocrinol (Copenh) 1980;95:177-180
101. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-1647
102. Kastelan D, Korsic M. Raloxifene (Evista) in the treatment of postmenopausal osteoporosis - the profile of the patient. Rheumatism 2005;52:67-70
103. Daniels IR, Layer GT. How should gynaecomastia be managed? ANZ J Surg 2003;73:213-216
104. Aslan G, Tuncali D, Terzioglu A, Bingul F. Periareolar-transareolar- perithelial incision for the surgical treatment of gynecomastia. Ann Plast Surg 2005;54:130-134
105. Morselli PG. "Pull-through": a new technique for breast reduction in gynecomastia. Plast Reconstr Surg 1996;97:450-454
106. Colombo-Benkmann M, Buse B, Stern J, Herfarth C. Indications for and results of surgical therapy for male gynecomastia. Am J Surg 1999;178:60-63